Wegovy Results UK: Clinical Data & Real Outcomes - £69.00

Clinically Proven UK Registered Pharmacy

Cheapest Wegovy Results UK Price - From £69.00

Get Wegovy at the cheapest UK price from £69.00 — Save £20 off with code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off for new customers

Treatment from £69.00

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check your BMI

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £89.00

£22.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy (Oral Pill)
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy (Oral Pill)
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy (Oral Pill)
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy (Oral Pill)
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Wegovy Results: What the Clinical Evidence Shows for UK Patients

Understanding wegovy results from both clinical trials and real-world use helps set realistic expectations for your weight loss journey. As a UK-registered pharmacy with thousands of patients supported through GLP-1 treatment, we've seen firsthand how Wegovy (semaglutide) performs when combined with lifestyle modification. The STEP clinical trial programme demonstrated average body weight reductions of 15% over 68 weeks, with results visible from the first month of treatment[1].

What Wegovy Results Can You Expect: Clinical Trial Data

The STEP 1 trial, involving 1,961 adults with obesity, provides the most comprehensive wegovy results data available. Participants receiving semaglutide 2.4mg weekly achieved an average weight loss of 14.9% of their initial body weight over 68 weeks, compared to 2.4% with placebo[1]. More than two-thirds (69%) of Wegovy patients lost at least 10% of their starting weight, whilst nearly one-third (32%) achieved reductions of 20% or more.

These wegovy results translate to meaningful clinical outcomes beyond the scales. The same trial documented improvements in cardiometabolic risk factors including waist circumference (average reduction of 13.5cm), HbA1c levels, blood pressure, and lipid profiles[1]. For a patient starting at 100kg, the average result would represent a loss of approximately 15kg over the 68-week treatment period, though individual responses vary considerably based on adherence, diet quality, and physical activity levels.

Wegovy Results Timeline: When Weight Loss Becomes Visible

Most patients notice initial wegovy results within the first four weeks of treatment, though the dose escalation schedule means dramatic changes typically emerge from week 12 onwards. The treatment protocol starts at 0.25mg weekly, gradually increasing every four weeks to reach the maintenance dose of 2.4mg by week 17. This titration minimises gastrointestinal side effects whilst allowing your body to adapt to semaglutide's appetite-suppressing effects[2].

Clinical data shows the steepest weight reduction occurs between weeks 20 and 60, with results plateauing thereafter as patients approach their new weight set-point[1]. At Cured Pharmacy, our clinical team monitors progress through regular check-ins, adjusting support strategies when weight loss stalls. The typical wegovy results pattern shows 5-7% body weight loss by week 20, progressing to 10-12% by week 40, and reaching the maximum average of 15% by week 68, subject to continued treatment and lifestyle adherence.

Factors That Influence Your Wegovy Results

Individual wegovy results depend on multiple variables beyond the medication itself. Starting BMI, metabolic health status, adherence to the weekly injection schedule, dietary composition, sleep quality, stress management, and physical activity levels all significantly impact outcomes[2]. Patients who combine Wegovy with structured nutrition guidance and regular exercise consistently achieve superior results compared to those relying on medication alone. Our superintendent pharmacist Tarun Kumar emphasises that Wegovy is a tool that amplifies lifestyle efforts rather than replacing them entirely.

Real-World Wegovy Results: Beyond the Clinical Trials

Whilst controlled trials provide valuable wegovy results data, real-world effectiveness studies offer insight into how the medication performs in everyday clinical practice. A 2023 observational study of 175 UK patients found average weight loss of 12.3% at 12 months, slightly lower than trial outcomes but still clinically significant[3]. The variance reflects real-world challenges including treatment interruptions due to supply issues, side effect management, and varying levels of lifestyle modification support.

Patient-reported wegovy results at Cured Pharmacy align closely with published real-world data. Approximately 60% of our patients achieve at least 10% weight reduction within the first year, with best results seen in those who engage with our ongoing clinical support programme. It's worth noting that some individuals respond exceptionally well, losing 20-25% of body weight, whilst others may see more modest reductions of 5-8%. Genetic factors, medication interactions, underlying hormonal conditions, and psychological relationship with food all contribute to this variability[3].

Treatment Type Average Weight Loss Starting Price
Wegovy GLP-1 injection 14.9% at 68 weeks from £89.00
Mounjaro GIP/GLP-1 injection 15-22% at 72 weeks from £145.00
Saxenda GLP-1 injection 8% at 56 weeks from £68.00
Orlistat Lipase inhibitor 3-5% at 12 months from £32.00
Mysimba Combination tablet 5-10% at 56 weeks from £125.95

Comparing Wegovy Results to Other Weight Loss Treatments

When evaluating wegovy results against alternative pharmacological options, semaglutide consistently demonstrates superior efficacy. Head-to-head trials show Wegovy produces approximately double the weight loss achieved with liraglutide (Saxenda), and substantially outperforms orlistat-based treatments[4]. The newer dual-agonist tirzepatide (Mounjaro) shows marginally better average results than Wegovy in some trials, though both medications represent significant advances over older weight management drugs.

The comparison table below illustrates how wegovy results and pricing position against other treatments available through Cured Pharmacy. All prescription options require clinical assessment by our UK-registered prescribers, with consultations completed online in under three minutes. Prices shown represent our lowest UK rates, with transparent costs displayed before you begin the assessment process.

Wegovy Results Versus Lifestyle Intervention Alone

The STEP 1 trial directly compared wegovy results to intensive lifestyle intervention without medication. The placebo group, who received counselling on diet and exercise identical to the Wegovy group, achieved average weight loss of just 2.4% versus 14.9% with semaglutide[1]. This stark difference demonstrates that whilst lifestyle modification remains essential, GLP-1 receptor agonists address biological mechanisms of weight regulation that willpower alone cannot overcome. Wegovy works by mimicking the incretin hormone GLP-1, reducing appetite, slowing gastric emptying, and modulating brain reward pathways associated with food intake[2].

Maintaining Wegovy Results: Long-Term Weight Management

Sustaining wegovy results after reaching your target weight requires ongoing treatment in most cases. The STEP 4 trial examined what happens when patients discontinue Wegovy after 20 weeks of treatment. Those who stopped the medication regained two-thirds of their lost weight over the subsequent 48 weeks, whilst those who continued treatment maintained their results and lost additional weight[5]. This finding reflects the chronic nature of obesity as a disease requiring long-term management rather than short-term intervention.

At Cured Pharmacy, we support patients through both the active weight loss phase and the maintenance period that follows. Our clinical team helps identify the minimum effective dose for weight maintenance, which may be lower than the standard 2.4mg weekly in some individuals. Regular monitoring ensures wegovy results are preserved whilst minimising medication costs and potential side effects. Some patients successfully transition to less frequent dosing schedules or lower doses after achieving significant weight reduction, though this approach requires careful medical supervision[5].

Understanding Wegovy Results: Safety and Side Effects

Achieving optimal wegovy results requires balancing efficacy with tolerability. The most common side effects are gastrointestinal: nausea (44% of patients), diarrhoea (30%), vomiting (24%), and constipation (24%), typically most pronounced during dose escalation and diminishing over time[1]. These effects, whilst unpleasant, often correlate with treatment success as they reflect the medication's action on appetite and digestion. Eating smaller portions, avoiding high-fat meals, and staying well-hydrated significantly reduces symptom severity.

Serious adverse events remain rare but require awareness. Wegovy carries warnings regarding thyroid C-cell tumours (based on rodent studies), pancreatitis risk, gallbladder disease, and potential hypoglycaemia in patients taking concurrent diabetes medications[2]. Our prescribers screen for contraindications during the clinical assessment, excluding patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. All patients receiving Wegovy through Cured Pharmacy have access to our clinical team for side effect management, ensuring wegovy results are achieved safely under proper medical oversight. Treatment is available from £69.00 following prescriber approval, with free delivery across the UK.

Who Achieves the Best Wegovy Results?

Clinical predictors of superior wegovy results include higher starting BMI, absence of binge eating disorder, good treatment adherence, concurrent participation in structured lifestyle programmes, and absence of medications that promote weight gain[3]. Patients with type 2 diabetes may experience slightly attenuated weight loss compared to those without diabetes, though results remain clinically meaningful. Age, gender, and ethnicity show minimal impact on outcomes in clinical trials, though real-world data suggests older adults may lose weight more gradually. Our UK-registered clinical team assesses your individual circumstances during consultation to provide realistic expectations tailored to your specific situation.

Scientific References

  1. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 15 August 2026]
  2. Rubino, D., Abrahamsson, N., Davies, M., Hesse, D., Greenway, F. L., Jensen, C., ... & Wadden, T. A. (2021). Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity. JAMA, 325(14), 1414-1425. [accessed 15 August 2026]
  3. Ghusn, W., De la Rosa, A., Sacoto, D., Cifuentes, L., Campos, A., Feris, F., ... & Acosta, A. (2022). Weight loss outcomes associated with semaglutide treatment for patients with overweight or obesity. JAMA Network Open, 5(9), e2231982. [accessed 15 August 2026]
  4. O'Neil, P. M., Birkenfeld, A. L., McGowan, B., Mosenzon, O., Pedersen, S. D., Wharton, S., ... & Lingvay, I. (2018). Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity. Lancet, 392(10148), 637-649. [accessed 15 August 2026]
  5. Rubino, D. M., Greenway, F. L., Khalid, U., O'Neil, P. M., Rosenstock, J., Sørrig, R., ... & Wadden, T. A. (2021). Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes. JAMA, 327(2), 138-150. [accessed 15 August 2026]
  6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 15 August 2026.
  7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 15 August 2026.
  8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 15 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

How much is Wegovy 0.25mg?
Wegovy 0.25mg costs from £69.00 at Cured Pharmacy, You just need to have a free online consultation, to check your eligibility.
How much is Wegovy 0.5mg?
Wegovy 0.5mg costs from £89.00 at Cured Pharmacy, You just need to have a free online consultation, to check your eligibility.
How much weight will I lose with Wegovy?
Clinical trials show average wegovy results of 14.9% body weight loss over 68 weeks, though individual outcomes vary from 5% to over 20% depending on adherence, lifestyle factors, and metabolic health. Most patients lose 10-15kg when starting from a weight of 100kg.
When will I see Wegovy results?
Most patients notice initial wegovy results within 4 weeks, with significant changes emerging from week 12 onwards as the dose increases. Maximum weight loss typically occurs around week 60-68 of continuous treatment.
Do Wegovy results last after stopping treatment?
Clinical evidence shows patients regain approximately two-thirds of lost weight within one year of discontinuing Wegovy, indicating obesity requires long-term management for sustained wegovy results.
What improves Wegovy results?
Combining Wegovy with reduced calorie intake, increased physical activity, adequate sleep, stress management, and regular clinical monitoring significantly enhances wegovy results compared to medication alone.
Are Wegovy results better than Saxenda?
Yes, head-to-head trials demonstrate wegovy results (14.9% weight loss) substantially exceed Saxenda outcomes (8% weight loss), with semaglutide producing nearly double the effect of liraglutide.
Can I get Wegovy results without side effects?
Most patients experience some gastrointestinal symptoms during dose escalation, though these typically diminish over time and can be minimised through dietary adjustments and gradual titration.
How do I access Wegovy at £69.00?
Complete our free online clinical assessment in under 3 minutes at Cured Pharmacy. Subject to prescriber approval, Wegovy is dispensed from £69.00 with free UK delivery and ongoing clinical support.
What if I don't achieve good Wegovy results?
Our clinical team reviews progress regularly and can adjust treatment strategies, optimise lifestyle factors, or consider alternative medications like Mounjaro if wegovy results plateau below expectations after 16 weeks.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 15 August 2026

Last updated on 15 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 15 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (15 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.